Tag: Patents
Understanding Patents vs. Copyrights: Safeguarding Your Creative Ideaslaw
May 14, 2025
When it comes to protecting your creative ideas, understanding the difference between a patent and a copyright is crucial. A patent is a legal right granted by the government, allowing the inventor to exclude others from making, using, selling, or…
Read MoreWho Really Invented CRISPR for Eukaryotic Cells? Federal Circuit Weighs In
May 12, 2025
Regents of the Univ. of Cal. v. Broad. Inst., Inc Authored by: Jeremy J. Gustrowsky The long-running patent dispute over who first invented the CRISPR-Cas9 gene-editing technology for use in eukaryotic cells—those found in plants, animals, and humans—took another turn…
Read MoreStanding Roadblock: Incyte’s Patent Appeal Dismissed for Lack of Concrete Plans
May 7, 2025
Incyte Corp. v. Sun Pharm. Indus., Inc Authored by: Jeremy J. Gustrowsky In a recent decision, the Federal Circuit dismissed Incyte Corporation’s appeal in its patent dispute with Sun Pharmaceutical Industries, Inc., highlighting the strict requirements for Article III standing…
Read MorePatent Invalidity Upheld: Public Use and IPR Estoppel Clarified in Ingenico v. IOENGINE
May 7, 2025
Ingenico Inc. v. Ioengine, LLC Authored by: Jeremy J. Gustrowsky In a significant decision for patent law, the Federal Circuit affirmed a jury verdict that found several claims of IOENGINE’s patents invalid, providing important guidance on what counts as “public…
Read MorePatent Reissue Claims: Federal Circuit Says Actual Claim Language, Not Inventor Intent, Controls Scope
May 6, 2025
In re Kostic Authored by: Jeremy J. Gustrowsky In a recent decision, the Federal Circuit clarified an important rule for patent owners seeking to broaden their claims through a reissue: what matters is the actual language of the original claims,…
Read MoreCourt Limits Patent Injunctions on Clinical Trials and FDA Applications in Jazz v. Avadel
May 6, 2025
Jazz Pharms., Inc. v. Avadel CNS Pharms., LLC Authored by: Jeremy J. Gustrowsky A recent decision in Jazz Pharmaceuticals, Inc. v. Avadel CNS Pharmaceuticals, LLC provides important guidance on how far patent owners can go in blocking competitors from conducting…
Read MoreFederal Circuit Finds “Payment Handler” Patent Claims Indefinite for Lack of Structure
April 30, 2025
Fintiv, Inc. v. Paypal Holdings, Inc Authored by: Jeremy J. Gustrowsky In a significant decision for software patents, the Federal Circuit recently affirmed the invalidation of several Fintiv, Inc. patents for indefiniteness, holding that the term “payment handler” failed to…
Read MoreFederal Circuit Clarifies Limits on Using “Admitted Prior Art” in Patent Challenges
April 23, 2025
Qualcomm Inc. v. Apple Inc Authored by: Jeremy J. Gustrowsky In a significant decision for patent law, the Federal Circuit has clarified how “applicant admitted prior art” (AAPA) can—and cannot—be used in inter partes review (IPR) proceedings. The case involved…
Read MoreI’ll Sell It First, Then Patent It Later: What You Need to Know About the U.S. Patent System
April 16, 2025
Did you know that the U.S. patent system allows inventors a whole year to file for patent protection after they first disclose their idea or put it up for sale? This is great news, but there are some important things…
Read MoreUK “Sterile” Label Sinks US Patent Claims: Sage Products Loses Appeal Over Chlorhexidine Patent
April 15, 2025
Sage Prods., LLC v. Stewart Authored by: Jeremy J. Gustrowsky In a recent decision, the Federal Circuit affirmed the invalidation of two patents owned by Sage Products, LLC, relating to sterilized chlorhexidine products used for skin disinfection. The patents in…
Read MorePatent Owner’s Own Words Sink Infringement Case Over Vancomycin Liquid Formulation
April 8, 2025
Azurity Pharms., Inc. v. Alkem Labs. Ltd Authored by: Jeremy J. Gustrowsky In a recent decision, the Federal Circuit affirmed that Azurity Pharmaceuticals, Inc. could not enforce its U.S. Patent No. 10,959,948 against Alkem Laboratories Ltd. because Azurity had clearly…
Read MoreIn re Riggs Clarifies Who Gets the Benefit of a Provisional Patent’s Filing Date
March 24, 2025
In re Riggs Authored by: Jeremy J. Gustrowsky The Federal Circuit recently decided In re Riggs which sheds new light on when a published patent application can use the filing date of its earlier provisional application to qualify as prior…
Read More